Ledger.Open graph →
SEC Form D · filed September 13, 2016

Atea Pharmaceuticals, Inc

Offering
$20.8M
Sold
$20.8M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
BOSTON, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Jean-Pierre Sommadossi, Ph.D · Boston, MAExec · DirectorBruno Lucidi · Boston, MADirectorBruce Polsky · Boston, MADirectorEvgeny Zatsev · Boston, MADirectorGerald Chan · CAUSEWAY BAY, Hong KongDirectorPaul M. Galvin · Brooklyn, NYDirectorSean M. Mcavoy · Burlingame, CADirectorSonia K. Lutchmiah · Moka, O4DirectorStevan S. Armstrong · Brooklyn, NYExec · DirectorMahesh S. Shetty · Brooklyn, NYDirectorFrank Yu · Boston, MADirectorBalan R. Ayyar · Brooklyn, NYDirectorA. M. Finkelstein · Newark, NJExec · DirectorLucien A. Alziari · Newark, NJDirectorZiad Khoury · Winter Park, FLDirectorJason Rottenberg · Winter Park, FLDirectorFrank Yu · Boston, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗